PDLIUnknown
PDL BIOPHARMA, INC. Insider Trading Activity
Every SEC Form 4 insider transaction reported for PDL BIOPHARMA, INC. (PDLI), sourced directly from SEC EDGAR and updated as new filings are accepted.
By Trabud Research Team · SEC Form 4 & insider trading data analysts
Last updated:
Quick Answer
Are PDLI insiders buying or selling?
PDL BIOPHARMA, INC. insiders reported 6 open-market buys ($31.9M) and 11 sells ($3.9M) across 17 Form 4 filings — a net buying position of $28.0M.
Source: SEC EDGAR Form 4
Key Statistics (as of Feb 3, 2021)
Total Form 4 filings
17
SEC EDGAR
Insider filers
7
Insider buys (6)
$31.9M
Insider sells (11)
$3.9M
Insider sentiment
Net buyingNet insider flow of $28.0M in net buying.
Recent PDLI insider transactions
| Date | Insider | Role | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Feb 3, 2021 | Silver Point Capital L.P. | 10% Owner | Purchase | 187.1K | $2.05 | $383.5K |
| Jan 4, 2021 | Silver Point Capital L.P. | 10% Owner | Purchase | 6.3M | $2.50 | $15.8M |
| Dec 31, 2020 | David W Gryska | Director | Sale | 20.0K | $2.74 | $54.8K |
| Dec 29, 2020 | Silver Point Capital L.P. | 10% Owner | Purchase | 631.6K | $2.69 | $1.7M |
| Dec 23, 2020 | Silver Point Capital L.P. | 10% Owner | Purchase | 1.6M | $2.60 | $4.1M |
| Dec 23, 2020 | John Peter Mclaughlin | Director | Sale | 327.9K | $2.61 | $855.8K |
| Dec 18, 2020 | Silver Point Capital L.P. | 10% Owner | Purchase | 1.7M | $2.59 | $4.5M |
| Dec 17, 2020 | Christopher Lewis Stone | VP, Gen. Counsel & Secretary | Sale | 200.0K | $2.56 | $512.0K |
| Dec 17, 2020 | Dominique Monnet | President and CEO | Sale | 500.0K | $2.60 | $1.3M |
| Dec 17, 2020 | David W Gryska | Director | Sale | 75.0K | $2.68 | $201.0K |
| Dec 16, 2020 | Silver Point Capital L.P. | 10% Owner | Purchase | 2.1M | $2.57 | $5.4M |
| Dec 5, 2020 | David W Gryska | Director | Sale | 75.0K | $2.52 | $189.0K |
| Nov 25, 2020 | Elizabeth G. O'Farrell | Director | Sale | 25.8K | $2.44 | $63.0K |
| Nov 25, 2020 | David W Gryska | Director | Sale | 50.0K | $2.43 | $121.5K |
| Nov 21, 2020 | Elizabeth G. O'Farrell | Director | Sale | 63.3K | $2.38 | $150.7K |
| Nov 21, 2020 | Alan Lee Bazaar | Director | Sale | 33.4K | $2.42 | $81.0K |
| Nov 19, 2020 | David W Gryska | Director | Sale | 150.0K | $2.40 | $359.5K |
Showing the 17 most recent of 17 Form 4 filings for PDL BIOPHARMA, INC..
Most active PDLI insiders
- Silver Point Capital L.P.6 filings
- David W Gryska5 filings
- Elizabeth G. O'Farrell2 filings
- Alan Lee Bazaar1 filing
- Christopher Lewis Stone1 filing
Ask anything about PDLI insider activity
Use Trabud's AI agent to query PDL BIOPHARMA, INC.'s Form 4 history in plain English — "Show me PDLI CEO purchases this year" or compare it against any other ticker.
Open the AI agentPDLI insider trading FAQ
Are PDL BIOPHARMA, INC. insiders buying or selling?
Across 17 SEC Form 4 filings, PDL BIOPHARMA, INC. (PDLI) insiders reported 6 open-market purchases totaling $31.9M and 11 sales totaling $3.9M. That is a net buying position of $28.0M.
How many insiders trade PDLI stock?
7 distinct insider filers — officers, directors, 10%+ owners, and investment groups filing jointly — have reported Form 4 transactions for PDL BIOPHARMA, INC.. The most recent filing was accepted on Feb 3, 2021.
Where does Trabud get PDLI insider trading data?
All PDLI insider trading data comes directly from official SEC EDGAR Form 4 filings, which corporate insiders must submit within two business days of a transaction under Section 16(a) of the Securities Exchange Act of 1934.
Looking for another company? Browse all tracked companies.